We are live on
!
Find out more
RPC
Rossmore Private Capital Portfolio holdings
AUM
$1.24B
1-Year Est. Return
28.92%
This Fund
S&P 500
This Quarter
Est. Return
+8.08%
1 Year Est. Return
+28.92%
3 Year Est. Return
+75.43%
5 Year Est. Return
+104.51%
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$26.8M
(+9%)
Cap. Flow
+$8.94M
Cap. Flow
% of AUM
2.76%
Top 10 Holdings %
Top 10 Hldgs %
47.24%
Holding
139
New
3
Increased
33
Reduced
40
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arvinas
ARVN
|
+$4.07M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.75M |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$1.34M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.27M |
| 5 |
JPMorgan Chase
JPM
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$8.07M |
| 2 |
CELG
Celgene Corp
CELG
|
+$544K |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$469K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$304K |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$244K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 23.68% |
| 2 | Healthcare | 10.61% |
| 3 | Technology | 9.56% |
| 4 | Financials | 9.11% |
| 5 | Consumer Staples | 5.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Dow Inc
DOW
$21.9B
| $238K | 0.07% |
4,345
-252
| -5% | -$13K |
|
127
General Motors
GM
$80.4B
| $234K | 0.07% |
6,400
| – | – |
|
128
Toronto Dominion Bank
TD
$198B
| $225K | 0.07% |
4,000
| – | – |
|
129
Bio-Techne
TECH
$11.2B
| $220K | 0.07% |
+4,000
| New | +$210K |
|
130
Darden Restaurants
DRI
$23.3B
| $218K | 0.07% |
2,000
| – | – |
|
131
Booking.com
BKNG
$149B
| $216K | 0.07% |
2,625
| – | – |
|
132
J.M. Smucker
SJM
$12.7B
| $206K | 0.06% |
1,978
-75
| -4% | -$7.94K |
|
133
iShares Biotechnology ETF
IBB
$9.34B
| $202K | 0.06% |
+1,674
| New | +$187K |
|
134
GE Aerospace
GE
$374B
| $197K | 0.06% |
3,539
| – | – |
|
135
Oramed Pharmaceuticals
ORMP
$167M
| $78K | 0.02% |
15,061
| – | – |
|
136
Globalstar
GSAT
$10.7B
| $19K | 0.01% |
2,460
| – | – |
|
137
State Street SPDR S&P China ETF
GXC
$462M
| – | – |
-2,545
| Closed | -$201K |
|
|
SCHW
138
Charles Schwab
SCHW
$183B
| – | – |
-193,000
| Closed | -$8.07M |
|
|
CELG
139
DELISTED
Celgene Corp
CELG
| – | – |
-5,475
| Closed | -$544K |
|
Similar funds
MP
GX
HCA
CCA
NHAS
FLII
IC
HTHT
Rossmore Private Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Rossmore Private Capital held 139 positions worth $324M, up 9% from $297M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 4.3%. Rossmore Private Capital opened 3 new positions and exited 3, leaving the 139-position portfolio largely intact.
By sector, the portfolio is most concentrated in Energy at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.
- Rossmore Private Capital's largest Q4 2019 buy was Arvinas: 138,914 shares worth $5.71M.
- Rossmore Private Capital added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.75M increase.
- Rossmore Private Capital's biggest Q4 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $469K.
- Rossmore Private Capital fully exited Charles Schwab in Q4 2019, selling an estimated $8.07M.
- Rossmore Private Capital's ten largest holdings make up 47% of its $324M portfolio in Q4 2019.
- Rossmore Private Capital opened 3 new positions and closed 3 in Q4 2019.
- Rossmore Private Capital's portfolio value rose 9% quarter-over-quarter to $324M.
Based on Rossmore Private Capital's 13F filing for Q4 2019, filed 10 Feb 2020.